Silvercrest Asset Management’s Nile Therapeutics, Inc. Common Stock NLTX Stock Holding History

Silvercrest Asset Management’s Portfolio NLTX Stock Details NLTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-10,000	Closed	–	–	475
2013 Q3	$0	Hold	10,000	–	–	﹤0.01%	463
2013 Q2	$0	Buy	+10,000	New	–	﹤0.01%	435

Silvercrest Asset Management's NLTX Position: Q4 2013 in Review

Silvercrest Asset Management sold out of Nile Therapeutics, Inc. Common Stock (NLTX) in Q4 2013, closing a stake of 10,000 shares.

Silvercrest Asset Management first reported a position in NLTX in Q2 2013 and held it in 2 quarters. The position peaked at $0 in Q3 2013. 0 funds tracked by Wall St. Rank hold NLTX as of Q4 2013.

Silvercrest Asset Management reported no remaining Nile Therapeutics, Inc. Common Stock position as of Q4 2013 after selling out during the quarter.
Silvercrest Asset Management sold 10,000 Nile Therapeutics, Inc. Common Stock shares in Q4 2013.
Silvercrest Asset Management first reported a position in Nile Therapeutics, Inc. Common Stock in Q2 2013 and held it in 2 quarters.
Silvercrest Asset Management's Nile Therapeutics, Inc. Common Stock position peaked at $0 in Q3 2013.
0 funds tracked by Wall St. Rank held Nile Therapeutics, Inc. Common Stock as of Q4 2013.

Based on Silvercrest Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.